WELL Health Receives Final Approval to Graduate to the TSX and will Ring Opening Bell at TSX Jan 9, 2020
Healthcare Roundup – Heska announces acquisition of CVM Companies, Lilly launches new robotic drug discovery laboratory Jan 9, 2020 Life Science
Healthcare Roundup – FDA OKs Merck’s Keytruda, Catabasis Pharma teams up with UK DMD charity Jan 8, 2020 Life Science
Chinese Drugmaker Aosaikang to Bring in Oral Iron Supplement From UK’s Shield Therapeutics Jan 8, 2020 Life Science
Healthcare Roundup – Genetic Tech up 95%, General Cannabis to acquire Hälsa Holdings Jan 7, 2020 Life Science
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies Jan 7, 2020 Life Science
DIAGNOS AI based clinical Eye Test for Diabetic Retinopathy Demonstrates Exceptional Performance at the CHUM, expands for an Additional Six Months Jan 7, 2020 Life Science
Healthcare Roundup – GlycoMimetics out-licenses two programs, OrthoPediatrics sells Vilex adult business Jan 6, 2020 Life Science
Biotech Co. Ltd. Announced Completion of Merger, Appointed Yingshuang Chai as CEO, and Established Collaboration with Illumina Jan 6, 2020 Life Science
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment Jan 6, 2020 Life Science
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing Jan 3, 2020 Life Science
Healthcare Roundup – MyoKardia inks $200M stock sales deal, Charles River Labs closes HemaCare acquisition Jan 3, 2020 Life Science
Healthcare Roundup – Illumina and Pacific Biosciences nix merger, Tilray inks deal to export weed into Israel Jan 2, 2020 Life Science
China approves home-grown vaccines, offering alternative to global drugmakers’ products Dec 31, 2019 Life Science
Healthcare Roundup – EyeGate Pharma files for 500K-share stock offering, Drugmakers to hike U.S. prices Dec 31, 2019 Life Science
Healthcare Roundup – XBiotech says bermekimab sale to J&J closes, Acceleron Pharma teams up with Fulcrum Therapeutics Dec 30, 2019 Life Science
